ConcertAI: ASCO 2024 study demonstrates that AI-based clinical trial screening is more than 3x faster than traditional methods

CAMBRIDGE, Mass., May 29, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study being presented at ASCO 2024 showing that its Digital Trial Solutions (DTS)…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.